General Information of the Compound
| Compound ID |
CP0050791
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S)-2-amino-3-(phosphonooxy)propanoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
LSOP
(+)-L-Serine dihydrogen phosphate (ester)
3-O-Phosphoserine
3-phosphoserine
407-41-0
Dexfosfoserine
Dexfosfoserine [INN]
Fosforina
H-Ser(PO)-OH
H-Ser(PO3H2)-OH
L-2-amino-3-hydroxypropanoic acid 3-phosphate
L-3-Phosphoserine
L-O-Phosphoserine
L-O-Serine phosphate
L-Phosphoserine
L-SOP
L-Serine O-phosphate
L-Serinephosphoric acid
L-Seryl phosphate
L-serine-O-phosphate
O-Phosphoserine
O-phospho-L-serine
O-phosphono-L-serine
PHOSPHONOSERINE
Phosphatidalserine
Phosphonoserine
Phosphoserine
UNII-VI4F0K069V
phosphoserine
serine, O-phosphono-
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C3H8NO6P
|
||||||||||||||||||
| Molecular Weight |
185.072
|
||||||||||||||||||
| Canonical SMILES |
N[C@@H](COP(O)(O)=O)C(O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BZQFBWGGLXLEPQ-REOHCLBHSA-N
|
||||||||||||||||||
| CAS |
407-41-0
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( L-serine-O-phosphate )
| Drug Name | L-serine-O-phosphate | ||
|---|---|---|---|
| Target(s) | |||